Literature DB >> 20410878

Hunting the hedgehog pathway.

G J Weiss1, D D Von Hoff.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20410878     DOI: 10.1038/clpt.2010.34

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  6 in total

1.  Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer.

Authors:  Tobias Kiesslich; Christian Mayr; Julia Wachter; Doris Bach; Julia Fuereder; Andrej Wagner; Beate Alinger; Martin Pichler; Pietro Di Fazio; Matthias Ocker; Frieder Berr; Daniel Neureiter
Journal:  Mol Cell Biochem       Date:  2014-07-27       Impact factor: 3.396

Review 2.  Molecular pathology and potential therapeutic targets in esophageal basaloid squamous cell carcinoma.

Authors:  Tsuyoshi Saito; Hiroyuki Mitomi; Takashi Yao
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  New agents for prevention of ultraviolet-induced nonmelanoma skin cancer.

Authors:  William L Camp; Jennifer W Turnham; Mohammad Athar; Craig A Elmets
Journal:  Semin Cutan Med Surg       Date:  2011-03

4.  Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease.

Authors:  Daniela Göppner; Martin Leverkus
Journal:  J Skin Cancer       Date:  2010-12-29

5.  Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome.

Authors:  Glen J Weiss; Raoul Tibes; Lisa Blaydorn; Gayle Jameson; Molly Downhour; Erica White; Ivor Caro; Daniel D Von Hoff
Journal:  Dermatol Reports       Date:  2011-12-01

6.  18-FDG PET/CT assessment of basal cell carcinoma with vismodegib.

Authors:  Curtis A Thacker; Glen J Weiss; Raoul Tibes; Lisa Blaydorn; Molly Downhour; Erica White; Jason Baldwin; Daniel D Hoff; Ronald L Korn
Journal:  Cancer Med       Date:  2012-09-17       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.